Detection and identification of atypical quetiapine metabolite in urine

Central European Journal of Medicine

Volumn 3, Issue 3, 2008, Pages 327-331

  Atanasov, Vasil N ^a,b   Kanev, Kamen P ^a   Mitewa, Mariana Io ^b  

^a MILITARY MEDICAL ACADEMY   (Bulgaria)

^b UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

GC MS screening; N desalkylquetiapine; Quetiapine

Indexed keywords

DRUG METABOLITE; N DESALKYLQUETIAPINE; QUETIAPINE;

ARTICLE; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; PRIORITY JOURNAL; URINALYSIS;

EID: 47249098378     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-008-0015-0     Document Type: Article

References (13)

1. Goldstein J., Arvanitis L. A., ICI 204,636 (Seroquel): A dibenzothiazepine atypical antipsychotic, Review of preclinical pharmacology and highlights of Phase II clinical trials, CNS Drug Rev., 1995, 1, 50-73
2. Arvanitis L. A., Miller B. G., Multiple fixed doses of 'seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 study Group, Biol. Psychiatry, 1997, 2, 233-46
3. Caccia S., New antipsychotic agents for schizophrenia: Pharmacokinetics and metabolism update, Curr. Opin. Invest. Drugs, 2002, 3, 1073-1080
4. De Vane C. L., Nemeroff C. B., Clinical Pharmacokinetics of Quetiapine: An Atypical Antipsychotic, Clin. Pharmacokinet., 2001, 40, 509-522
5. Hasselstrom J., Linnet K., In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions, Drug Metabol. Drug Interact., 2006, 21, 187-211
6. Flammia D. D., Valouch T., Venuti S., Tissue distribution of quetiapine in 20 cases in Virginia, J. Anal. Toxicol., 2006, 30, 287-292
7. Hopenwasser J., Mozayani A., Danielson T. J., Harbin J., Narula H. S., Posey D. H., et al., Postmortem Distribution of the Novel Antipsychotic Drug Quetiapine, J. Anal. Toxicol., 2004, 28, 264-268
8. Langman L. J., Kaliciak H. A., Carlyle S., Fatal overdoses associated with quetiapine, J. Anal. Toxicol., 2004, 28, 520-525
9. Saracino M. A., Mercolini L., Flotta G., Albers L. J., Merli R., Raggi M. A., Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography, J. Chromatogr. B, 2006, 843, 227-233
10. Mandrioli R., Fanali S., Ferranti A., Raggi M. A., HPLC analysis of the novel antipsychotic drug quetiapine in human plasma, J. Pharm. Biomed. Anal., 2002, 30, 969-977
11. Anderson D.T., Fritz K.L.Quetiapine (Seroquel®) concentrations in seven postmortem cases, J. Anal. Toxicol., 2000, 24, 300-304
12. Davis P. C., Wong J., Gefvert O., Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection, J. Pharm. Biomed. Anal., 1999, 20, 271-282
13. Schulz M., Schmoldt A., Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics, Pharmazie, 2003, 58, 437-474